trending Market Intelligence /marketintelligence/en/news-insights/trending/taczr3_qqataqdbei6z0aa2 content esgSubNav
In This List

Magellan Health revises FY'18 guidance

Podcast

Private Markets 360° | Episode 8: Powering the Global Private Markets (with Adam Kansler of S&P Global Market Intelligence)

Blog

Kensho Launches Word Error Rate Calculator

Blog

Insight Weekly: Bank oversight steps up; auto insurers’ dismal year; VC investment slumps

Blog

Bank failures: The importance of liquidity and funding data


Magellan Health revises FY'18 guidance

Magellan Health Inc. has revised its guidance for 2018.

The company now expects net income to be in the range of $125 million to $149 million, compared with the previous expected range of $114 million to $138 million. It is maintaining its projected revenue range at $7.5 billion to $7.8 billion.

Adjusted net income is projected to be in the range of $163 million to $183 million, compared to previous guidance of $143 million to $163 million. The company now expects adjusted EPS to be between $6.37 and $7.15, compared to the prior guidance of $5.68 to $6.47.

Magellan Health also reported fourth-quarter 2017 adjusted net income of $64.2 million, or $2.55 per share, versus $42.4 million, or $1.80 per share, in the year-ago period.